PHARMEINSA

Sankt Vith ·KBO/BCE: BE 0787.352.463

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	17-03-2026	136 d early	2026-00055862
31-12-2024	31-07-2025	20-03-2025	133 d early	2025-00051187
31-12-2023	31-07-2024	04-04-2024	118 d early	2024-00057291
31-12-2022	31-07-2023	13-04-2023	109 d early	2023-00059598

Metric	This company	Sector median	Position in the sector
Solvency	0.7%	13.7%	better than 25% of 247 sector peers
Net result	€146k	€19k	better than 80% of 247 sector peers
Equity	€5k	€93k	better than 25% of 247 sector peers
Gross operating margin	€247k	€323k	better than 41% of 218 sector peers
Staff costs	€31k	€287k	higher than 8% of 218 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€757k
Fixed assets	21/28	€74k
Tangible fixed assets	22/27	€67k
Financial fixed assets	28	€7k
Current assets	29/58	€683k
Stocks & contracts in progress	3	€92k
Amounts receivable within one year	40/41	€56k
Cash & bank	54/58	€527k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€757k
Equity	10/15	€5k
Contributions / capital	10/11	€5k
Accumulated profits (losses)	14	€42
Amounts payable	17/49	€752k
Amounts payable within one year	42/48	€752k
Trade debts payable within one year	44	€71k
Income statement
Gross operating margin	9900	€247k
Operating result	9901	€190k
Financial income	75	€29
Financial charges	65	€306
Result before taxes	9903	€190k
Income taxes	67/77	€44k
Net result for the period	9904	€146k
Result to be appropriated	9905	€146k

Summary